Intrinsiqq
Lunai Bioworks Inc. logo

Lunai Bioworks Inc.

LNAI

⊜ Compare
⚠ Showing the latest available close (Oct 29, 2026, 7 days ago). Our price provider hasn't published a newer EOD for this ticker yet. Price-dependent metrics (P/E, P/FCF, yield) may not reflect current market conditions.

As of June 30, 2026, Lunai Bioworks Inc. operated principally through two operating subsidiaries, Renovaro Biosciences and BioSymetrics; a third wholly owned subsidiary, Lunai Bioworks IP, Inc., holds the intellectual property acquired in the May 2026 Neurobridge acquisition, including the N2B intranasal drug delivery platform. BioSymetrics refers to BioSymetrics Inc. and its wholl…

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$830K
EPS-$1.06
P/E-0.16
P/FCF-0.16
EV/EBITDA0.06
FCF Yield–
Div. Yield–
Net Debt/FCF0.3x
Lunai Bioworks Inc. intrinsic value
52-Week Range
$0.17$0.47

Profitability & Returns

Revenue (TTM)

$52K

Net Income (TTM)

-$4M

▲ +98.0% YoY

Op. Margin

-16729.37%

ROIC

-1031.25%

▼ -809.3pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$5M

▲ +32.8% YoY

Op. Cash Flow (TTM)

-$5M

▲ +32.8% YoY

Net Debt

-$1M

Net Cash Position

Cash & Equiv.

$2M

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with LNAI

CompareIntrinsic value
OWPCOne World Products Inc.
$0.00+0.00%46
SILOSilo Pharma Inc.
$1.33+3.91%10
AVTXAvalo Therapeutics Inc.
$7.07-2.48%10
ALTAltimmune, Inc.
$2.12+3.92%10
NTHINeonC Technologies Holdings
$3.17+3.26%10
OGENOragenics Inc.
$0.37+0.00%20
BPTHBio-Path Holdings Inc.
$0.00+66.67%20
OTLCOncotelic Therapeutics Inc.
$0.02-17.00%10

Lunai Bioworks (LNAI) in four numbers

Fair value (revenue)
$0.12
Price $0.16 is 34% above it.
Intrinsic Value
Quality score
10/100
Best check: net debt, -$1M. Weakest: return on capital, -1031.2%.
Quality
Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-0.16
Negative: a loss over the last twelve months. Price to free cash flow -0.16.
Financials

Questions about Lunai Bioworks

Is Lunai Bioworks (LNAI) overvalued?

At $0.16, Lunai Bioworks' price is 34% above the $0.12 a share fair value that Intrinsiqq's calculator gets from its revenue. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is Lunai Bioworks' fair value?

Intrinsiqq's calculator puts Lunai Bioworks' fair value at $0.12 a share. It grows revenue per share 5% a year for 5 years, applies an exit P/S of 15, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $0.09. Every input can be changed on the Intrinsic Value tab.

Is Lunai Bioworks a high-quality business?

Lunai Bioworks scores 10 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 4 checks computed from SEC filings. Its best check is net debt at -$1M, and its weakest is return on capital at -1031.2%. The Quality tab shows every check against its target.

Does Lunai Bioworks (LNAI) pay a dividend?

No. Lunai Bioworks (LNAI) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 13 Oct 2026 (period ending 30 Jun 2026), SEC. Price: last close 29 Oct 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in LNAI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing LNAI

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.